Detalhe da pesquisa
1.
A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia.
Blood
; 139(19): 2931-2941, 2022 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35007321
2.
Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea.
Blood
; 134(18): 1498-1509, 2019 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31515250
3.
Does the frequency of molecular monitoring after tyrosine kinase inhibitor discontinuation affect outcomes of patients with chronic myeloid leukemia?
Cancer
; 123(13): 2482-2488, 2017 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28241101
4.
Primary analysis of a phase II open-label trial of INCB039110, a selective JAK1 inhibitor, in patients with myelofibrosis.
Haematologica
; 102(2): 327-335, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27789678
5.
Momelotinib in myelofibrosis: JAK1/2 inhibitor with a role in treating and understanding the anemia.
Future Oncol
; 13(5): 395-407, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27785927
6.
Predicting early blast transformation in chronic-phase chronic myeloid leukemia: is immunophenotyping the missing link?
Cancer
; 121(6): 872-5, 2015 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25387987
7.
A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis.
N Engl J Med
; 366(9): 799-807, 2012 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22375971
8.
Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I.
Haematologica
; 100(4): 479-88, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25616577
9.
Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies.
Haematologica
; 99(2): 292-8, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23911705
10.
Incidence and geographic distribution of adult acute leukemia in the state of Georgia.
South Med J
; 107(8): 497-500, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25084186
11.
Phase 2 study of add-on parsaclisib for patients with myelofibrosis and suboptimal response to ruxolitinib: final results.
Blood Adv
; 8(6): 1515-1528, 2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38290135
12.
Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies.
Cancer
; 119(21): 3784-7, 2013 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23921838
13.
The clinical benefit of ruxolitinib across patient subgroups: analysis of a placebo-controlled, Phase III study in patients with myelofibrosis.
Br J Haematol
; 161(4): 508-16, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23480528
14.
Efficacy, safety and survival with ruxolitinib in patients with myelofibrosis: results of a median 2-year follow-up of COMFORT-I.
Haematologica
; 98(12): 1865-71, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24038026
15.
Early clearance of peripheral blood blasts predicts response to induction chemotherapy in acute myeloid leukemia.
Cancer
; 118(21): 5278-82, 2012 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22517268
16.
High-dose cytarabine induction is well tolerated and active in patients with de novo acute myeloid leukemia older than 60 years.
Cancer
; 118(2): 428-33, 2012 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21717443
17.
Characteristics and outcomes of diffuse large B-cell lymphoma presenting in leukaemic phase.
Br J Haematol
; 158(5): 608-14, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22758202
18.
Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial.
Nat Med
; 27(12): 2183-2191, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34873347
19.
Comanagement Strategy Between Academic Institutions and Community Practices to Reduce Induction Mortality in Acute Promyelocytic Leukemia.
JCO Oncol Pract
; 17(4): e497-e505, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33125295
20.
Outcomes of Chronic Phase Chronic Myeloid Leukemia after Treatment with Multiple Tyrosine Kinase Inhibitors.
J Clin Med
; 9(5)2020 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32443762